We are moving!

Hi!

Our blog will now be available on our brand new website!

Don’t hesitate to follow us on our new blog to stay connected and get latest information about neurology and digital health.

Hope to see you soon!

Advertisements

New version of MedCalc for Apple Watch

We just released a new version of our Medical for Apple Watch application!

Version 2.2 introduces new scores and tools:

  • Ideal body weight calculation is now included with BMI and BSA
  • Corticosteroid equivalence calculator
  • CAGE questionnaire (screening of alcoholism)
  • Centor Score (probability of strep pharyngitis)

Medical for Apple Watch is a great tool for physicians and medical students. Previous versions already contained several tools including:

  • BMI, BSA calculation
  • eGFR
  • Cardiovascular scores:
    ABCD2, CHA2DS2 VASc, corrected QT, HEART Score, PE probability

It is fully optimized for Watch OS2!

The price ($0.99) remains unchanged! So don’t hesitate to take a look and try by yourself by clicking here

 

 

Discover the most powerful medical calculator available on Apple Watch

pubFB v2 Continue reading “Discover the most powerful medical calculator available on Apple Watch”

PML risk stratification using anti-JCV antibody index and L-selectin

Natalizumab treatment is associated with progressive multifocal leukoencephalopathy (PML) development. Treatment duration, prior immunosuppressant use, and JCV serostatus are currently used for risk stratification, but PML incidence stays high. Anti-JCV antibody index and L-selectin (CD62L) have been proposed as additional risk stratification parameters.

OBJECTIVE:

This study aimed at verifying and integrating both parameters into one algorithm for risk stratification.

METHODS:

Multicentric, international cohorts of natalizumab-treated MS patients were assessed for JCV index (1921 control patients and nine pre-PML patients) and CD62L (1410 control patients and 17 pre-PML patients).

RESULTS:

CD62L values correlate with JCV serostatus, as well as JCV index values. Low CD62L in natalizumab-treated patients was confirmed and validated as a biomarker for PML risk with the risk factor “CD62L low” increasing a patient’s relative risk 55-fold (p < 0.0001). Validation efforts established 86% sensitivity/91% specificity for CD62L and 100% sensitivity/59% specificity for JCV index as predictors of PML. Using both parameters identified 1.9% of natalizumab-treated patients in the reference center as the risk group.

CONCLUSIONS:

Both JCV index and CD62L have merit for risk stratification and share a potential biological relationship with implications for general PML etiology. A risk algorithm incorporating both biomarkers could strongly reduce PML incidence.

via Multiple Sclerosis Journal

Major upcoming update for our stroke app!

We are preparing a major update for our stroke application for iOS and Apple Watch!

Here is a first screenshot of the brand new dashboard. More news to come soon!

iPhone_6_Vert_SpaceGray_sRGB_0914 (Copie en conflit de iMac de Mikael Cohen 2015-06-01)

You can get the current version of the app on the AppStore here!

Easily Calculate BMI, body surface area and eGFR on Apple Watch

Body mass index (BMI) and estimated glomerular filtration rate (eGFR) are widely used in medical practice.

Many smartphone applications already exist and allow to calculate those parameters automatically depending on patient’s height, weight, age, blood creatinin…

We recently developed an app to get those tools directly on your wrist using Apple Watch!  Continue reading “Easily Calculate BMI, body surface area and eGFR on Apple Watch”